CRNX Trading Below CEO's Recent Buy Price

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 3, Crinetics Pharmaceuticals Inc's CEO, Richard Scott Struthers, invested $65,000.00 into 5,000 shares of CRNX, for a cost per share of $13.00..